EDITH UTLEY: Open Payments
NPI 1003951658 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,913 in 145 payments from 16 companies in 2025. Trend: 2023 $3,714 · 2024 $3,303 · 2025 $2,913
Food & beverage: $2,879Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 43 | $972 |
| GlaxoSmithKline, LLC. | 41 | $690 |
| GENZYME CORPORATION | 12 | $245 |
| Verona Pharma, Inc. | 10 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $206 |
| Regeneron Healthcare Solutions, Inc. | 7 | $201 |
| Insmed, Inc. | 6 | $100 |
| Grifols USA, LLC | 2 | $55 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| ANI Pharmaceuticals, Inc. | 2 | $34 |
Products named: FASENRA, DUPIXENT, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, OFEV, AIRSUPRA, TEZSPIRE.
Industry payments across GA — which companies pay providers there.
